Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Most patients with gastro-oesophageal reflux disease are treated in
primary care, but the effects of treatment in this population are not
well investigated. On p 550 Hatlebakk et al report on a community
based multicentre trial of 483 patients with heartburn who were
randomised to treatment with either cisapride, omeprazole, or placebo
for eight weeks. Control of heartburn after four and eight weeks was
achieved in 71%-76% of patients receiving omeprazole. Cisapride was
not significantly superior to placebo at any time, and adverse events
were more common with cisapride. Acid suppression seems to be the first
choice for empirical treatment of heartburn in patients in primary care.
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care